ADiTx Therapeutics logo
ADiTx Therapeutics ADTX
report update icon

Quarterly report 2026-Q1
added 11-21-2026

ADiTx Therapeutics Depreciation & Amortization | ADTX

Annual Depreciation & Amortization ADiTx Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
269 K 614 K 435 K 429 K 369 K 17.8 K - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
614 K 17.8 K 356 K

Quarterly Depreciation & Amortization ADiTx Therapeutics

2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
834 833 833 834 833 - 833 833 833 27.3 K 26.8 K 26.8 K 26.8 K 26.8 K 26.8 K 26.8 K 26.8 K 27 K 27 K 26.7 K 26.4 K 15 K 2.8 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
27.3 K 833 15.7 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer Depreciation & Amortization Price % 24h Market Cap Country
Brickell Biotech Brickell Biotech
BBI
41 K - -5.38 % $ 6.06 M usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
4.93 M - - $ 344 M usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
-339 K - - $ 25.3 M usaUSA
Merus N.V. Merus N.V.
MRUS
2.29 M - - $ 5.78 B niderlandNiderland
RAPT Therapeutics RAPT Therapeutics
RAPT
1.2 M - - $ 2.36 B usaUSA
Annexon Annexon
ANNX
2.17 M $ 3.11 -8.94 % $ 482 M usaUSA
Acasti Pharma Acasti Pharma
ACST
7 K - 4.01 % $ 150 M canadaCanada
Aptose Biosciences Aptose Biosciences
APTO
22 K - -45.71 % $ 1.2 M canadaCanada
Galapagos NV Galapagos NV
GLPG
55.9 M - - $ 1.83 B belgiumBelgium
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
1 K - -4.36 % $ 27 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
83 K $ 4.63 21.05 % $ 20 M israelIsrael
Achieve Life Sciences Achieve Life Sciences
ACHV
228 K $ 6.78 0.89 % $ 296 M usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
5 K - 368.57 % $ 41.9 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
44 K - - $ 35.3 M usaUSA
Axcella Health Axcella Health
AXLA
412 K - -16.42 % $ 249 M usaUSA
Metacrine Metacrine
MTCR
295 K - - $ 24.2 M usaUSA
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
1.38 M - -0.04 % $ 2.62 B usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
100 K - -23.04 % $ 26.6 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
18 K - - $ 3.67 B usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
1.06 M - - $ 69.7 B britainBritain
Atreca Atreca
BCEL
5.46 M - -11.76 % $ 5.79 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
19.4 K - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
94.5 K - - $ 109 M usaUSA
Akouos Akouos
AKUS
2.49 M - 0.23 % $ 488 M usaUSA
ImmunoGen ImmunoGen
IMGN
1.78 M - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
257 K - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
154 K - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
30 K - - $ 591 K irlandaIrlanda
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
48.2 K - -2.99 % $ 2.47 M usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
77 K - - $ 23.9 M usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
257 K - 31.87 % $ 1.61 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
140 K - -4.8 % $ 255 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
274 K - -0.23 % $ 916 M usaUSA
bluebird bio bluebird bio
BLUE
60.3 M - - $ 546 M usaUSA
Landos Biopharma Landos Biopharma
LABP
577 K - 0.58 % $ 144 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
1.2 M - - $ 35.4 M usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
154 K - -5.16 % $ 5.39 M usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
1.26 M - - $ 728 M usaUSA
Regulus Therapeutics Regulus Therapeutics
RGLS
347 K - - $ 155 M usaUSA
NGM Biopharmaceuticals NGM Biopharmaceuticals
NGM
2.22 M - - $ 127 M usaUSA
Aravive Aravive
ARAV
886 K - -13.39 % $ 1.45 M usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
66 K - - $ 231 M usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
3.9 M $ 84.95 0.13 % $ 7.99 B usaUSA